Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial from Zhejiang Cancer Hospital is investigating the combination of hepatic arterial infusion chemotherapy and immunotherapy for hepato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: RECRUITING